RVLP
RVL Pharmaceuticals plc Ordinary Shares
RVLP
RVLP
Delisted
RVLP was delisted on the 20th of October, 2023.
34 hedge funds and large institutions have $50.9M invested in RVL Pharmaceuticals plc Ordinary Shares in 2018 Q4 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$11.6M |
| 2 |
DM
Deerfield Management
New York
|
+$8.82M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$7.15M |
| 4 |
BC
Broadfin Capital
New York
|
+$4.1M |
| 5 |
BlackRock
New York
|
+$3.68M |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $31K | +$31K | +4,132 | New |
|
27
UBS Group
Zurich,
Switzerland
| $28K | +$28K | +3,602 | New |
|
28
JPMorgan Chase & Co
New York
| $22K | +$22K | +2,936 | New |
|
|
RA
29
Royce & Associates
New York
| $21K | +$21K | +2,745 | New |
|
|
SO
30
STRS Ohio
Columbus,
Ohio
| $20K | +$20K | +2,600 | New |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| $16K | +$16K | +2,127 | New |
|
32
Legal & General Group
London,
United Kingdom
| $12K | +$12K | +1,520 | New |
|
|
AIP
33
Ameritas Investment Partners
Lincoln,
Nebraska
| $6K | +$6K | +800 | New |
|
34
Citigroup
New York
| $5K | +$5K | +591 | New |
|